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Introduction
In animal cells, the duplication of the centrosome and its struc­
tural stability depend on centrioles (Sluder and Rieder, 1985; 
Bobinnec et al., 1998). Centrioles, or basal bodies, are found in 
a wide variety of eukaryotic species and probably originate in a 
common ancestor (Baroin et al., 1988).
In human cells, centrioles display a structural polarity, 
with stable triplet microtubules at their proximal end and dou­
blet microtubules at their distal end (Paintrand et al., 1992; 
Rousselet et al., 2001). In addition, mature centrioles harbor 
two sets of appendages at their distal ends, which are thought to 
be required for anchoring microtubules at the centriole, and for 
docking centrioles at the plasma membrane during ciliogenesis 
(Piel et al., 2000; Ishikawa et al., 2005).
During G1 phase of the cell cycle, the centrosome con­
tains a mature centriole, referred to as the mother centriole, and 
an immature centriole assembled during the previous cell cycle, 
referred to as the daughter centriole. Centriole duplication is 
first seen during S phase by the appearance of procentrioles that 
form at right angles to the proximal ends of preexisting centrioles 
(Robbins and Gonatas, 1964; Robbins et al., 1968; Kuriyama and 
Borisy, 1981; Vorobjev and Chentsov Yu, 1982). Procentrioles 
elongate as the cell cycle progresses to reach nearly full length 
in mitosis. During prophase, the two new centrosomes, each con­
taining a parental and a newly formed centriole, migrate apart and 
organize the mitotic spindle. Procentrioles become daughter cen­
trioles after mitosis, and it is only after a second mitosis that these 
centrioles become fully mature mother centrioles, bearing the 
two sets of distal appendages (Vorobjev and Chentsov Yu, 1982). 
Thus, centriole assembly and the maturation cycle encompass 
three successive cell cycles.
In the past few years, numerous data obtained from di­
verse model organisms have allowed us to draw a much clearer 
picture of the mechanisms governing the initial steps of centri­
ole duplication (for review see Bettencourt­Dias and Glover, 
2007). However, the fine structural changes and the associated 
molecular mechanisms that underlie centriole elongation and 
maturation remain poorly understood.
C
entrin has been shown to be involved in centro-
some biogenesis in a variety of eukaryotes. In 
this study, we characterize hPOC5, a conserved 
centrin-binding protein that contains Sfi1p-like repeats. 
hPOC5 is localized, like centrin, in the distal portion of 
human  centrioles.  hPOC5  recruitment  to  procentrioles 
occurs during G2/M, a process that continues up to the 
full maturation of the centriole during the next cell cycle 
and is correlated with hyperphosphorylation of the pro-
tein. In the absence of hPOC5, RPE1 cells arrest in G1 
phase, whereas HeLa cells show an extended S phase 
followed by cell death. We show that hPOC5 is not re-
quired for the initiation of procentriole assembly but is 
essential for building the distal half of centrioles. Interest-
ingly, the hPOC5 family reveals an evolutionary diver-
gence between vertebrates and organisms like Drosophila 
melanogaster or Caenorhabditis elegans, in which the 
loss of hPOC5 may correlate with the conspicuous differ-
ences in centriolar structure.
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be a putative component of human centrosomes by mass spectrom­
etry analysis (Andersen et al., 2003). A candidate C. reinhardtii 
homologue called POC5 (proteome of centriole 5) has also been 
found in centriole fractions (Keller et al., 2005). Therefore, we 
called the human protein hPOC5.
A full­length cDNA encoding the 575­aa hPOC5 protein 
was cloned by RT­PCR from HeLa RNA extracts. The amino acid 
sequence of hPOC5 predicted three putative Sfi1p­like CBRs. 
Two of them defined a tandem repeat after the consensus sequence 
[F/W/L]X2W[R/K]X21­34[F/W/L]X2W[R/K] found in Sfi1 protein 
family members (Fig. 1, a and b; Kilmartin, 2003; Li et al., 2006). 
In addition, two short coiled­coil domains are predicted on both 
sides of the tandem repeat.
Homologues of hPOC5 are found in many eukaryotic spe­
cies, including vertebrates, the green algae C. reinhardtii, and the 
protists Trypanosoma brucei, Leishmania major, Giardia lamblia, 
and Paramecium tetraurelia (Fig. 1, b and c), indicating a very an­
cient origin. Overall sequence conservation between POC5 family 
members is moderate (mean 16% identity and 29% similarity be­
tween distantly related species) with the exception of a very con­
served sequence of 21 aa (mean 57% identity and 81% similarity). 
All of the potential hPOC5 homologues contain the tandem repeat 
of centrin­binding sequences and the short coiled­coil regions. 
Potential homologues of hPOC5 are not found in the genomes of 
Saccharomyces cerevisiae and Dictyostelium discoideum, which 
do not assemble centrioles; they are also absent in the malarial 
parasite Plasmodium falciparum, in insects, and in nematodes.
hPOC5 binds human centrin proteins
It has been shown that the CBRs of hSfi1 protein bind in a simi­
lar manner to the different mammalian centrin proteins (Kilmartin, 
2003). We wanted to confirm the interaction between hPOC5 
and hCen2 and determine whether it also binds to hCen3, which 
belongs to another centrin subfamily (Azimzadeh and Bornens, 
2004). To this end, we have used GST pull­down experiments. 
The sequence of hPOC5 was first divided into three parts (F1–3; 
Fig. 2 a), which were then fused to GST and coexpressed with 
untagged hCen2 or hCen3 in Escherichia coli. Only the F2 frag­
ment, which contains the putative CBRs, was able to pull down 
either hCen2 or hCen3 (Fig. 2 b). To analyze the binding of cen­
trin proteins further, F2 subdomains containing the first CBR 
(CBR1) or the tandem repeat (CBR2+3; Fig. 2 a) were fused to 
GST and incubated with 5 µM purified hCen2, hCen3, or human 
CaM. In these experiments, CBR1 was not able to bind centrin 
proteins (Fig. 2 c). In contrast, CBR2+3 bound hCen2 and hCen3 
but not CaM. The results presented in Fig. 2 were obtained in 
low­Ca concentrations (10 mM EGTA), but similar results were 
obtained using Ca­containing buffers (5 mM CaCl2; not depicted). 
Thus, the hPOC5 protein is able to directly bind both hCen2 and 
hCen3 proteins in a Ca­independent manner through the region 
containing the two evolutionarily conserved centrin­binding 
motifs. The interaction between hPOC5 and centrin proteins 
appears to be specific, as hPOC5 does not bind CaM, which is a 
protein closely related to centrin.
To determine whether these interactions occur in vivo, we 
performed immunoprecipitation experiments using affinity­ 
purified anti­hPOC5 polyclonal antibodies (Fig. 2 e). These   
In most eukaryotes, members of the centrin family are 
found associated with the centrioles, basal bodies, and associ­
ated structures. Centrin proteins have several specific locations 
within centrioles/basal bodies and axonemes (Levy et al., 1996; 
Paoletti et al., 1996; Laoukili et al., 2000; Lemullois et al., 2004; 
Geimer and Melkonian, 2005; Ruiz et al., 2005; Stemm­Wolf et al., 
2005) and are also components of various fiber systems asso­
ciated with basal bodies in a spectrum of organisms (Salisbury 
et al., 1988; Madeddu et al., 1996). In human cells, the ubiqui­
tous centrin proteins hCen2 and hCen3 are recruited very early 
to assembly sites of procentrioles and are found within the distal 
lumen of full­length centrioles (Paoletti et al., 1996; Middendorp 
et al., 1997; Laoukili et al., 2000). Centrin proteins have been 
proposed to play a role in centriole assembly, as knockout of 
the Tetrahymena thermophila or Chlamydomonas reinhardtii 
homologues of hCen2 prevents centriole/basal body duplication 
(Koblenz et al., 2003; Stemm­Wolf et al., 2005), although a 
similar requirement for centrin proteins in mammalian centro­
some duplication remains controversial (Salisbury et al., 2002; 
Kleylein­Sohn et al., 2007). This function could also be con­
served in higher fungi, although centriolar structure is lost in 
this lineage during evolution (Adams and Kilmartin, 2000). The 
budding yeast centrin Cdc31p and its homologue in fission yeast 
are indeed required for the duplication of spindle pole bodies, 
which are the acentriolar centrosomes of fungi (Baum et al., 
1986; Paoletti et al., 2003).
Despite their evolutionary conservation and their common 
association with centriolar structures, the precise functions of cen­
trin proteins await characterization. Like CaM, to which they   
are closely related, centrin proteins could interact with several 
partners to ensure flagellar apparatus or centrosome­associated 
functions as well as other apparently unrelated processes such as 
DNA repair and mRNA export (Araki et al., 2001; Fischer et al., 
2004; Nishi et al., 2005). A conserved centrin­interacting pro­
tein associated with centrosomes, Sfi1p, has been first identified 
in yeast. Like Cdc31p, Sfi1p is essential for spindle pole body 
duplication, and its human homologue localizes to the centri­
oles in human cells (Kilmartin, 2003).
In this study, we report the characterization of a novel, con­
served centrin­binding protein containing centrin­binding repeats 
(CBRs) similar to those found in Sfi1p. This protein, which we 
called hPOC5, is concentrated at the distal end of centrioles. We 
show that hPOC5 is not required for initial procentriole formation 
but is required for the assembly of the distal portion of centrioles 
and progression into G2 phase of the cell cycle.
Results
Identification of hPOC5, an evolutionarily 
conserved centrin-binding protein
We have used a two­hybrid approach to identify proteins inter­
acting with human centrin proteins hCen2 or hCen3. Screening 
human two­hybrid libraries using full­length or a C­terminal   
region (aa 93–173) of hCen2 led to the identification of five 
partial cDNA clones corresponding to the same region of the 
GenBank/EMBL/DDBJ (NM_001099271) mRNA sequence. It 
encodes the C5orf37/FLJ35779 protein, which has been found to 103 hPOC5 IS REQUIRED FOR CENTRIOLE ELONGATION • Azimzadeh et al.
cells progressed through mitosis and the following interphase 
(Fig. 3 b). As shown in Fig. 3 c, hPOC5 staining was not affected 
by the complete disassembly of microtubules obtained with no­
codazole treatment, indicating that hPOC5 associated with the 
centrioles in a microtubule­independent manner.
To confirm the predominant localization of hPOC5 at cen­
trosomes, we performed a cellular fractionation analysis (Fig. 3 d). 
hPOC5 protein was enriched in fractions containing nuclei and 
centrosomes and enriched even further in isolated centrosomes. 
Enrichment in hPOC5 was more pronounced in the lymphoid cell 
line KE37 than in HeLa cells as the result of better centrosome 
isolation in the former cell line. However, with both cell types, 
centrosome fractions were enriched in slow migrating forms of 
hPOC5. We tested whether the electrophoretic pattern was caused 
by the phosphorylation of hPOC5 (Fig. 3 e). Nuclei and centro­
some fractions from HeLa cells incubated with ­phosphatase 
only displayed two bands co­migrating with the two prominent 
soluble forms (Fig. 3 e, left). This suggests that hPOC5 is subject 
to multiple phosphorylation events upon recruitment in centri­
oles. To determine whether phosphorylation of hPOC5 was cell 
cycle dependent, we analyzed the migration pattern of hPOC5 in 
interphase or mitotic HeLa cell extracts (Fig. 3 e, right). The mi­
gration pattern did not vary as cells progressed through G1, S, 
and G2 phases (unpublished data). However, in mitotic extracts, 
migration of the two soluble isoforms was shifted toward higher 
antibodies react predominantly with a doublet of bands in lysates 
from HeLa cells and with bands of slightly higher molecular 
weight in insoluble fractions (Fig. 2, d and e). The doublet of 
bands migrated at ≥75 kD, which is higher than the predicted 
size (65 kD). The intensity of the major bands was reduced both 
in lysates and in insoluble fractions after RNAi treatment, indi­
cating that they corresponded to hPOC5 (Fig. 2 d). Anti­hPOC5 
antibodies immunoprecipitated endogenous hCen2 and hCen3 
from lysates (Fig. 2 e). The reverse coimmunoprecipitation   
assay showed that hPOC5 coprecipitated either with hCen2 or 
hCen3. These data suggest that hPOC5 is associated with both 
hCen2 and hCen3 in vivo.
hPOC5 is a centriolar protein
In immunofluorescence microscopy, anti­hPOC5 antibodies pref­
erentially labeled two dots in interphase cells (Fig. 3 a). These 
dots corresponded to individual centrioles, as judged by colocal­
ization with GFP­hCen1 (Fig. 3 b). Centriolar localization was 
also confirmed by expression of full­length hPOC5 fused to GFP 
(unpublished data). hPOC5 localized at mother and daughter cen­
trioles throughout the cell cycle (Fig. 3 b). The recruitment of 
centrin proteins in the procentrioles occurs during early S phase 
(Paoletti et al., 1996; Middendorp et al., 1997; Piel et al., 2000). 
In contrast, anti­hPOC5 staining of the procentrioles was detected 
from G2 phase only. It was then seen in increasing amounts as 
Figure 1.  hPOC5 is a conserved protein. (a) Schematic representation of hPOC5 and predicted homologues in C. reinhardtii and P. tetraurelia. The 
putative Sfi1p-like CBRs are indicated in pink, the predicted coiled-coil regions are indicated in green, and the conserved 21-aa signature domain indi-
cated in orange. The size of the predicted full-length proteins is indicated. (b) Alignment of the central region of POC5 family members: human (available 
from GenBank/EMBL/DDBJ under accession no. NP_001092741), zebrafish (XP_691080), sea urchin (XP_797483), T. brucei (XP_822994), L. major 
(XP_001686847), G. lamblia (XP_001705095.1), C. reinhardtii (version 3.0 available from the Chlamydomonas Center under accession no. 144089), 
and P. tetraurelia (available from the Paramecium Database under accession no. GSPATP00029936001). Positions at which ≥75% of amino acid residues 
are identical or similar between proteins are shaded. Identical residues are shaded in black, and similar residues are shaded in gray. Domains depicted 
in panel a are reported using the same colors on the protein sequences. (c) ClustalW phylogenetic tree of the POC5 family based on the neighbor-joining 
method. 1,000 replicates were performed. Bootstrap values are displayed as percentages at each node. Bar, 0.1 substitutions/1 aa.JCB • VOLUME 185 • NUMBER 1 • 2009   104
level (Fig. 3 f). Thin sections of HeLa cells were labeled 
with anti­hPOC5 (10­nm gold particles) and anti­hCen3 anti­
body (5­nm gold particles) using a postembedding technique. 
Appropriate sections of centrosomes show that the 10­nm 
gold is found predominantly in the distal part of centrioles, 
colocalizing to a large extent with the 5­nm gold label repre­
senting hCen3.
apparent molecular weights. When treated with ­phosphatase, 
the mitotic isoforms were shifted back to an apparent molecular 
weight similar to the interphase forms. Thus, soluble hPOC5 is 
phosphorylated during mitosis, and centrosome­associated hPOC5 
appears to undergo additional phosphorylation events.
Finally,  immunogold  labeling  experiments  were  per­
formed to study the distribution of hPOC5 at the ultrastructural 
Figure 2.  hPOC5 binds human centrin proteins through the conserved Sfi1p-like repeats. (a) Maps of the GST fusions used in b and c on a schematic 
representation of hPOC5 in which CBRs are shown in black, coiled-coil domains are shown in gray, and the POC5 signature domain is outlined in black.   
(b) GST fusions F1–3 were coexpressed in E. coli with hCen2 or hCen3 and pulled down using glutathione beads. T, total E.coli extract; B, beads. (c) Fusions 
containing only the first predicted CBR (CBR1) or the central conserved tandem repeat (CBR2+3) were bound to glutathione beads and incubated with 5 µM 
untagged hCen2, hCen3, or CaM. S, supernatant after the pull-down. In b and c, the GST fusions are indicated by an asterisk, and hCen2/3 or CaM is 
indicated by an arrow. (d) Affinity-purified anti-hPOC5 labels a major band in HeLa cell lysates that can be further resolved into a doublet and slow migrat-
ing species in insoluble extracts, which are decreased by treatment with hPOC5 siRNA1. An insoluble polypeptide of 45 kD that is not affected by RNAi, 
likely resulting from a cross-reaction, is indicated by an asterisk. Ins, insoluble; Lys, lysate. (e) Anti-hPOC5 but not control antibody immunoprecipitated 
endogenous hCen2/3 from HeLa cell lysates (left). Similarly, endogenous hPOC5 was immunoprecipitated by anti-hCen2 and anti-hCen3 (right). SN, 
IP supernatant; IP, immunoprecipitated material. (b–e) Molecular mass is indicated in kilodaltons.105 hPOC5 IS REQUIRED FOR CENTRIOLE ELONGATION • Azimzadeh et al.
In contrast, in hPOC5­depleted HeLa cells, up to 90% of the cells 
had only one centriole labeled by anti­hPOC5 antibody (Fig. 4 d).
This phenotype could be caused by the inhibition of centri­
ole duplication leading to a reduced number of centrioles. Alter­
natively, centriolar structures may assemble without incorporating 
hPOC5. Colabeling with other centriolar markers such as centrin 
(Fig. 4 b) or polyglutamylated tubulin (Fig. 4 c) revealed that 
hPOC5 is stably incorporated in  
mother centrioles
To determine the function of hPOC5, we reduced its cellular pro­
tein level using siRNAs. Treatment of HeLa cells with specific 
siRNAs significantly reduced hPOC5 protein levels as compared 
with control siRNA (Fig. 4 a). Approximately 90% of control inter­
phase cells had two brightly stained centrioles (Fig. 4, b and d). 
Figure 3.  hPOC5 is a centriolar phosphoprotein. (a) HeLa cell stained with affinity-purified anti-hPOC5 antibody (shown in red) and anti–-tubulin antibody 
(shown in green). DAPI is shown in blue. (b) Localization of hPOC5 during the cell cycle. RPE1 cells expressing the GFP-Cen1 construct were labeled with 
affinity-purified anti-hPOC5 and anti-PCNA antibody. S cells exhibit a nuclear PCNA staining; among PCNA-negative cells, GFP-Cen1 allows us to distin-
guish G1 cells that have a single centrosome from G2 cells that have duplicated centrosomes. hPOC5 is shown in red, GFP-Cen1 is shown in green, PCNA 
is shown in blue, and DAPI is shown in gray on merged pseudocolor images. (c) Control or nocodazole-treated HeLa cells labeled with anti-hPOC5 (red) 
and anti-tubulin (green). DAPI is shown in blue. (d) hPOC5 is highly enriched in centrosome fractions. Centrosome-nucleus (NC) or isolated centrosome (C) 
fractions prepared from HeLa and KE37 cells or KE37 cells only, respectively, were stained with anti-hPOC5 or anti–C-Nap1 as a marker. T, total protein 
extract. (e) hPOC5 is a phosphoprotein. (left) Centrosome-nucleus fractions were incubated with -phosphatase (+) or buffer alone () and stained with 
anti-hPOC5. (right) hPOC5 immunoprecipitated from mitotic (M) or interphase (I) HeLa cell lysates was incubated with -phosphatase (+) or buffer alone 
() and revealed with anti-hPOC5. Lys, lysate; IP, immunoprecipitated material. (d and e) Molecular mass is indicated in kilodaltons. (f) Postembedding 
immunogold colocalization of hPOC5 (10-nm gold particles) and hCen3 (5-nm gold particles) in HeLa cells. (a and c) Insets show magnifications of the 
boxed areas. Bars: (a–c) 10 µm; (f) 0.2 µm.JCB • VOLUME 185 • NUMBER 1 • 2009   106
Figure 4.  hPOC5 is stably incorporated into mother centrioles. (a) hPOC5 levels in HeLa cells treated for 48 h with two different hPOC5 siRNAs or control 
siRNA. Anti-tubulin was used as a loading control. (b, top) G1 (left) or S/G2 (right) GFP-Cen1–expressing cells treated with control or hPOC5 siRNA 1 for 48 h 
and stained with anti-hPOC5 (red). (bottom) siRNA-treated HeLa cells labeled with anti-hPOC5 (red) and CTR453 antibody recognizing centrosome-associated 
AKAP450 or anti–C-Nap1 (green). (c) RPE1 cells treated with control or hPOC5 siRNA 1 and stained with anti-hPOC5 (green) and anti–polyglutamylated 
tubulin antibody GT335 (Glu Tub; red). DAPI is shown in blue. Insets show magnifications of the centrosome area. (d) Quantification of the number of cen-
trioles labeled by anti-hPOC5 in control and hPOC5 siRNA–treated cells over time. Values are from a single experiment representative of four experiments. 
(e) Quantification of hPOC5 levels in GFP-Cen1–expressing cells treated with hPOC5 siRNAs for 1–3 d. The values are shown as percentages of the mean 
fluorescence intensity of the mother centriole in control cells. In hPOC5-depleted cells, hPOC5 fluorescence intensity associated with daughter centrioles 
labeled by GFP-Cen1 was indistinguishable from the background levels and could not be quantified using the same method (ND). Results were obtained 
from three different experiments. Error bars represent SD. (d and e) n = total number of cells counted. Bars: (b) 1 µm; (c) 10 µm.107 hPOC5 IS REQUIRED FOR CENTRIOLE ELONGATION • Azimzadeh et al.
represents the amount of hPOC5 that is stably incorporated into 
centrioles. In contrast, hPOC5 was not detected at the younger, 
immature centrioles either because it was not incorporated in 
centrioles that formed after the siRNA treatment or because it 
was not stably associated to immature centrioles.
hPOC5 is an essential protein
We found that upon hPOC5 siRNA treatment, centrioles lacking 
hPOC5 but containing other centriolar markers were assembled. 
If siRNA­treated cells were progressing through the cell cycle, 
we would expect to observe an accumulation of cells containing 
no hPOC5­stained centriole because of the dilution over succes­
sive cell divisions of the mature centrioles formed before hPOC5 
depletion. However, this was not the case, as most of the cells 
retained one hPOC5­containing mother centriole even at 72 h 
after siRNA treatment (Fig. 4 d). We could observe mitotic cells 
in which only the mother centriole was hPOC5 stained (Fig. 5 a), 
but we could not trace such cells past telophase (Fig. 5 a). In 
particular, we did not find daughter cells connected by a mid­
body with hPOC5­free centrosomes. This suggests that these 
cells are not viable. Therefore, we analyzed the growth of cells 
centriolar structures depleted of hPOC5 were present. The 
amounts of pericentriolar proteins AKAP450 and C­Nap1 asso­
ciated to centrioles appeared similar in hPOC5­depleted cells 
and in control cells (Fig. 4 b, bottom). In hPOC5­depleted GFP­
Cen1–expressing cells, anti­hPOC5 staining was associated with 
one of two (in G1 and early S cells) or one of four (in S/G2/M 
cells) GFP­stained centrioles (Fig. 4 b, top). Similar results were 
obtained for cells with endogenous centrin proteins stained with 
20H5 monoclonal antibody (Fig. S1; Salisbury et al., 2002). The 
remaining hPOC5 staining was associated with the more brightly 
GFP­Cen1–stained centriole (Fig. 4 b), which has been shown to 
be the mother centriole (Piel et al., 2000). This result was con­
firmed using ciliated RPE1 cells. In siRNA­treated RPE1 cells, 
the remaining hPOC5 signal was always associated with the 
mother centriole that nucleates the cilium (Fig. 4 c). Thus, centro­
some duplication occurred in hPOC5 siRNA–treated cells, but the 
nonmature centrioles assembled during the last two cell cycles 
were devoid of hPOC5.
The mean hPOC5 fluorescence intensity associated with 
the mother centriole in hPOC5 siRNA–treated cells was 40 ± 
20% of that of control cells (Fig. 4 e). This intensity likely 
Figure 5.  hPOC5 is an essential protein. (a) Dividing GFP-Cen1–expressing HeLa cells after 48-h treatment with hPOC5 siRNA 1 and stained with anti-
hPOC5 (red) and anti-tubulin (blue). Insets show magnifications of each spindle pole area. (b) Cell growth is affected by hPOC5 depletion. HeLa cells 
were siRNA treated twice at t = 0 and 2 d later and fixed at designated time points, and cell growth was determined after violet crystal staining (OD570). 
Results were obtained from three independent measurements in three independent experiments. Mean values ± SD are shown. (c) Fate of HeLa cells treated 
with hPOC5 siRNA 1 observed by time-lapse imaging. (top) Experimental protocol. Asynchronous HeLa cells were treated with hPOC5 siRNA 1 or control 
siRNA and video recorded for 65 h starting 6 h after the beginning of siRNA treatment. I, interphase; M, mitosis. (bottom) Percentages of interphase cells 
that either died, arrested in interphase until the end of the recording, or entered mitosis during interphase 2 (left) or 3 (right). (d) hPOC5-depleted cells 
exhibit a delay in interphase. Duration of mitosis and interphase of HeLa cells treated with hPOC5 siRNA 1 or control siRNA. Results in c and d were 
obtained by analysis of time-lapse images of individual cells from two independent experiments. n = total number of cells counted. Error bars represent SD. 
Bar, 10 µm.JCB • VOLUME 185 • NUMBER 1 • 2009   108
we observed a significant increase in the proportion of S­phase 
cells (46% compared with 30% in controls). We confirmed 
these results by analyzing BrdU incorporation, as revealed by 
immunostaining: hPOC5­depleted cells showed a higher propor­
tion of BrdU­positive cells when compared with control cells (65% 
vs. 30–35%; Fig. 6 b). A defect in S­phase progression was not 
observed after simultaneous depletion of hCen2 and hCen3 or 
after depletion of hSfi1, which is the human homologue of yeast 
Sfi1p, suggesting that progression through S phase is specifically 
affected by hPOC5 depletion (Fig. S3).
It has been shown that nontransformed cells like RPE1 cells 
arrest at the G1/S transition of the cell cycle after the depletion of 
a variety of centrosome components and that this arrest is p53 and 
p21 dependent (Srsen et al., 2006; Mikule et al., 2007). Accord­
ingly, we observed that a fraction of RPE1 cells treated with 
hPOC5 siRNAs arrested in G1 phase (Fig. S2). In HeLa cells, p53 
is inactivated by the expression of human papillomavirus proteins 
E6 and E7, and this G1 arrest is not observed (Srsen et al., 2006). 
We confirmed that p53 is fully inactive in our HeLa cell line by 
analyzing the induction of p21 in response to irradiation. DNA 
damage induced by irradiation is known to induce up­regulation 
of p53, which, in turn, induces p21 up­regulation. After  irradia­
tion with 10 Gy, RPE1 cells exhibited a robust p21 up­regulation 
(Fig. 6 c). In contrast, p21 was not up­regulated in HeLa cells, 
confirming that p53 is inactive in this cell line. Thus, the mecha­
nism by which hPOC5 inactivation induces a delay in S­phase 
progression in HeLa cells is distinct from the G1/S­phase arrest 
induced by centrosome disruption in RPE1 cells.
hPOC5­depleted  cells  exhibited  an  extended  S  phase, 
during which the assembly of procentrioles normally occurs. 
Accordingly, the proportion of cells with two pairs of dots labeled 
with GFP­Cen1 was increased in hPOC5 siRNA–treated HeLa 
depleted of hPOC5. As shown in Fig. 5 b, cells treated with 
hPOC5 siRNA 1, which induces the strongest hPOC5 depletion 
(Fig. 4, a and e), exhibited a severe growth defect. siRNA 2 had 
a milder effect but, nevertheless, induced a significant decrease 
in cell number. To determine how cell growth was affected, we 
used video recording of nonsynchronized HeLa cells treated with 
hPOC5 siRNA 1 (Fig. 5, c and d) starting 6 h after the begin­
ning of the siRNA treatment. The fate of cells entering mitosis 
0–8 h after the beginning of recording was analyzed over a time 
period of 65 h. As expected, 80% of control cells went through 
three rounds of mitosis (Fig. 5 c). The mean durations of inter­
phase and mitosis (Fig. 5 d) were very similar for the successive 
cell cycles (mean of 22.3 ± 3.9 h for interphase and 53 ± 26 min 
for mitosis). In contrast, only 20% of cells entered a third mi­
tosis in hPOC5 siRNA 1–treated cells. Although the duration of 
interphase 2 (23.9 ± 5.4 h) and mitosis 2 (53 ± 20 min) were 
similar to control cells, most cells seemed to be delayed during 
interphase 3, as they had not entered a third mitosis at the end 
of the time lapse (33.4 ± 6.7 h). In addition, we observed a sig­
nificant increase in the rate of cell death in hPOC5­depleted 
cells during both cell cycles 2 and 3 (25% and 32% of the inter­
phase cells, respectively) as compared with control cells (9% 
and 6% of the cells, respectively). Thus, HeLa cells depleted of 
hPOC5 have a growth defect, which results from interphase 
delay and cell death.
hPOC5-depleted cells arrest  
during S phase in a p53- and  
p21-independent manner
To determine whether cells were arrested at a particular stage of 
interphase, we analyzed hPOC5­depleted cells by flow cytometry 
(Fig. 6 a). In HeLa cells treated with hPOC5 siRNA 1 for 72 h, 
Figure 6.  hPOC5-depleted cells arrest in S phase. (a) HeLa 
cells  were  treated  with  hPOC5  siRNAs  for  72  h  and   
analyzed  by  flow  cytometry.  Results  are  from  a  single   
experiment representative of three experiments. (b) Cell 
cycle analysis of hPOC5- or control siRNA–treated GFP-
Cen1 HeLa cells after BrdU incorporation and cyclin B1 
staining. Results were obtained from two independent ex-
periments. (c) HeLa and RPE1 cells were irradiated with   
10 Gy of  irradiation and subjected to Western blot analy-
sis. -Tubulin was used as a loading control. Molecular 
mass is indicated in kilodaltons. (d) siRNA-depleted cells 
accumulate in S phase with duplicated centrosomes. RNAi   
was  performed  in  GFP-Cen1–expressing  cells,  and  the 
number of GFP-stained centrioles per cell was counted.   
Results were obtained from three independent experiments.   
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cells corresponding to two pairs of postmitotic cells connected by 
a cytoplasmic bridge and 10 individual cells were analyzed. Each 
of the four cells forming the two pairs had one centrosome contain­
ing two full­length centrioles. Among the 10 individual cells, 9 had 
duplicated centrosomes, each containing a full­length centriole and 
an orthogonally arranged procentriole (Fig. 7, a and b). In these 
cells, the length of the procentrioles was 39% of the length of ma­
ture centrioles (180 ± 50 nm for procentrioles vs. 458 ± 77 nm 
for mature centrioles). In addition, the diameter of these procentri­
oles appeared smaller in longitudinal sections (Fig. 7, a and b). 
Accordingly, transverse sections revealed that procentrioles were 
formed by doublet microtubules instead of triplets (Fig. 7, e and f). 
Procentrioles of similar length and diameter have been shown to 
correspond to an early step of centriole duplication, taking place 
cells compared with control cells (Fig. 6 d). After the treatment 
with hPOC5 siRNA 1, the proportion of cells with duplicated 
centrosomes reached 70% after 48–72 h, as compared with 
45% for controls. Thus, hPOC5 depletion induces an accumu­
lation of cells in S phase where procentriole assembly has been 
apparently properly initiated.
Procentriole elongation is blocked in 
hPOC5-depleted cells
To determine whether hPOC5­depleted cells were arrested at a 
specific stage of procentriole assembly, we used EM of serial­
sectioned HeLa cells treated with hPOC5 siRNA 1. As siRNA 
treatment affects a large proportion of cells (90%), the cells sub­
jected to serial sectioning were selected randomly. 14 interphase 
Figure 7.  hPOC5-depleted HeLa cells accumu-
late with short procentrioles. (a and b) HeLa cells 
treated with hPOC5 siRNA 1 for 48 or 72 h were 
glutaraldehyde fixed and randomly selected for 
serial-thin sectioning. Panels a and b show two 
consecutive  sections  of  the  same  centrosome. 
Arrows show the procentrioles. (c–e) HeLa cells 
were treated with siRNA 1 for 48 h, and round-
shaped cells were collected by mitotic shake-off 
and glutaraldehyde fixed. Panels c, d, and e 
show three consecutive sections of the same cen-
trosome. Panel f shows a magnification of the 
procentriole seen in the transverse section in e. 
(g) Elongation of the procentriole was estimated 
by measuring the distance between the center 
of mass of the two dots of GFP-Cen1 staining 
within each pair of orthogonally arranged cen-
trioles (DCen) in GFP-Cen1–expressing HeLa cells 
with duplicated centrosomes. The graph shows 
the mean value of the highest 20% of values ob-
tained from series of 100 measurements ± SD. 
The highest values are obtained when DCen is 
parallel to the plan of imaging and, thus, repre-
sent a better approximation of the real distance. 
DCen was measured in control cells synchronized 
by a double thymidine block at the indicated 
time points after thymidine washout (2–10 h) as 
well as in synchronized control cells arrested in S 
phase by HU treatment for 37 h (HU-37 h). These 
values were compared with DCen measured in 
cells treated by hPOC5 siRNAs 1 and 2 that 
exhibited duplicated centrosomes. Micrographs 
show the GFP-Cen1 staining in a representative 
cell for each condition. (h) Schematic representa-
tion of DCen measured in diplosomes from early 
S- or G2-phase cells. The center of mass of the 
GFP staining (gray circles) is assumed to be cen-
tered on the distal end of each centriole. Bars: 
(a–e) 0.5 µm; (f) 0.1 µm.JCB • VOLUME 185 • NUMBER 1 • 2009   110
To summarize, hPOC5­depleted cells are able to initiate 
the assembly of procentrioles, but these procentrioles fail to 
elongate. Furthermore, this defect in procentriole elongation is 
clearly distinct from what is observed in cells arrested in S phase 
by HU and, thus, appears to be a direct consequence of hPOC5 
depletion rather than a secondary effect of S­phase arrest.
Discussion
hPOC5 defines a new family of centrin­binding proteins that share 
a tandem of Sfi1p repeats that can bind both hCen2 and hCen3 in 
vitro. The noncentrosomal pool of hPOC5 physiologically inter­
acts with hCen2 and hCen3, and the centrosome­associated 
hPOC5 colocalizes with both centrin proteins in the distal lumen 
of the centriole, in which a conspicuous and poorly characterized 
structure is present (Paintrand et al., 1992). Unlike centrin, hPOC5 
is recruited in centrioles late in the duplication process, namely 
during G2/M. In the absence of hPOC5, HeLa cells accumulate in 
S phase. In these cells, centriole duplication has been initiated, but 
the procentrioles subsequently fail to elongate. Therefore, hPOC5 
is essential for the assembly of full­length centrioles and for cell 
proliferation. Our results further suggest that the assembly of 
proximal and distal parts of centrioles is controlled separately and 
that hPOC5 is required for the latter part of this process.
hPOC5 is a centriolar centrin-binding 
protein
Centrin has been shown to be one of the very first proteins recruited 
at procentriole assembly sites (Middendorp et al., 1997; Klink and 
Wolniak, 2001; Koblenz et al., 2003; Stemm­Wolf et al., 2005). In 
mammalian cells, centrin is recruited there during early S phase, 
before the assembly of procentriole microtubules (Middendorp   
et al., 1997). In contrast, hPOC5 was not detected in the procentri­
oles before G2. Thus, it is likely that other centrin­interacting pro­
teins are involved in the initial steps of procentriole assembly. In 
addition, centrin proteins appear to have partners within the distal 
part of elongated centrioles, as hPOC5­depleted centrioles are still 
positive for centrin staining, although to a lesser extent than 
control centrioles (Figs. 5 a and 7 g). Candidate centriolar centrin­
interacting proteins include the vertebrate homologue of Sfi1p 
and CP110 protein, although a direct interaction has not been 
demonstrated for the latter (Kilmartin, 2003; Tsang et al., 2006).
After hPOC5 is first detected at the distal end of procen­
trioles in G2/M, it keeps accumulating during the next cell cycle 
together with hCen2/3 proteins. We show that the hPOC5 solu­
ble pool is phosphorylated during mitosis and that the centriole­
associated hPOC5 fraction is hyperphosphorylated, suggesting 
a possible phosphorylation­dependent recruitment of hPOC5 to 
the centriole. The progressive recruitment of hPOC5 in centri­
oles suggests that it may play a role in centriole maturation.
hPOC5 is required for cell cycle 
progression
We found that in the absence of hPOC5, HeLa cells accumulate 
in S phase, whereas RPE1 cells arrest in G1 phase. Previous 
studies have shown that, in nontransformed cell lines like RPE1, 
affecting centrosome integrity by depleting or mislocalizing a 
during early S phase in human cell lines (Robbins et al., 1968; 
Loncarek et al., 2008). To determine more precisely at which step 
of the centrosome duplication cycle procentrioles of similar length 
are normally observed, we used centrin staining as a marker for   
procentriole elongation. It has been shown that the distance sepa­
rating the two dots of centrin staining associated to a pair of or­
thogonally oriented centrioles increases during progression into 
S and G2 phases, reflecting the elongation of the procentriole (Piel 
et al., 2000; Loncarek et al., 2008). To further establish that the 
distance between centrin dots (DCen; Fig. 7 h) can provide a quan­
titative estimation of procentriole elongation, we measured DCen at 
various steps of centrosome duplication (Fig. 7 g). GFP­Cen1– 
expressing HeLa cells were synchronized at the G1/S boundary 
by a double thymidine block and fixed every 2 h after thymidine 
washout. The experiment was carried on until the onset of the mi­
totic wave (10 h after washout). At that time point, measurements 
were obtained from cells that had not yet rounded up for mitosis, 
which were likely to be in the G2 phase of the cell cycle. We ob­
served a gradual increase in the mean value of DCen as cells pro­
gressed through S and G2 phases, confirming that centrin staining 
is a reliable marker for procentriole elongation (Fig. 7 g). We then 
measured DCen in cells depleted from hPOC5 over 72 h and found 
that for both hPOC5 siRNAs, the mean value of DCen was less than 
in synchronized cells 2 h after thymidine washout. This result 
strongly supports the fact that procentrioles in hPOC5­depleted 
cells are similar in length to procentrioles observed during early 
steps of centrosome duplication, which is in agreement with our 
EM observations (Fig. 7 g). It has been shown that procentriole 
elongation only partially takes place in cells arrested in S phase 
for prolonged periods (Rattner and Phillips, 1973; Loncarek et al., 
2008). However, comparing EM data obtained by Loncarek et al. 
(2008) using the same cell line with this study supports the fact 
that procentrioles extend further in hydroxyurea (HU)­arrested 
cells than in hPOC5­depleted cells. To confirm this observation, 
we measured DCen in HeLa cells synchronized by mitotic shake­
off and cultured in the presence of HU for 37 h, which is an amount 
of time similar to that used previously (40 h; Loncarek et al., 2008) 
and similar to the interphase arrest in hPOC5­depleted cells (33.4 h; 
Fig. 5 d, I3). In HU­arrested cells, the mean value of DCen was 
similar to what we measured in late S­phase cells (8 h after thymi­
dine washout) and, thus, was significantly higher (P < 2 × 10
­06) 
than in hPOC5­depleted cells. Interestingly, DCen in HU­treated 
cells did not reach the G2­phase value (10 h after thymidine wash­
out) despite the prolonged S­phase arrest, suggesting that the tran­
sition  into  G2  phase  is  required  for  further  elongation  of  the 
procentrioles (Fig. 7 g).
Finally, we wanted to look at the ultrastructure of centri­
oles in hPOC5­depleted cells that were able to enter mitosis. To 
this aim, we collected cells by mitotic shake­off 48 h after incu­
bation with hPOC5 siRNA 1. However, we found that a vast 
majority of these cells were not in mitosis despite their round 
shape. Six of these cells were subjected to serial sectioning and 
EM analysis. Five of them had duplicated centrioles with short, 
cartwheel­containing  procentrioles,  confirming  our  observa­
tions on spread interphase cells (Fig. 7, c–f). In addition, some 
procentrioles were disengaged from the parental centriole wall 
in three of these cells (Fig. S4).111 hPOC5 IS REQUIRED FOR CENTRIOLE ELONGATION • Azimzadeh et al.
by fluorescence microscopy using centrin staining as a marker 
for procentriole elongation that procentrioles in hPOC5­depleted 
cells are similar in length to these found during early steps of 
centrosome duplication.
In mammalian cells, initiation of centriole duplication is 
followed by elongation of the procentrioles during S and G2 
phases (Kuriyama and Borisy, 1981; Vorobjev and Chentsov Yu, 
1982; Chretien et al., 1997). This process has been proposed to 
depend on cell cycle progression, as procentrioles in cells ar­
rested in S phase by DNA synthesis inhibitors are only partially 
elongated (Rattner and Phillips, 1973; Loncarek et al., 2008). 
Our results confirm these observations and further show that 
procentrioles in HU­arrested cells can reach the maximal length 
observed in control S­phase cells but that additional elongation 
requires transition into G2 phase. Procentrioles assembled in 
the absence of hPOC5 are clearly shorter and narrower than the 
procentrioles observed by EM in cycling HeLa cells during late 
S phase (Robbins et al., 1968) or in the HeLa cells arrested in   
S phase with HU (Loncarek et al., 2008). This conclusion is also 
strongly supported by our analysis of centrin staining. Together, 
our results suggest that initiation of centriole duplication occurs 
in the absence of hPOC5 but that subsequent elongation is in­
hibited. The observed defect is markedly distinct from the par­
tial elongation in drug­induced S­phase arrest, which suggests 
that hPOC5 is directly required for centriole elongation.
It is intriguing that hPOC5 depletion affects procentriole 
assembly during early S phase, as hPOC5 is first detected at the 
procentrioles during G2 phase in control cells (Fig. 3 b). Also, 
hPOC5 siRNA–treated cells contain an apparently full­length 
daughter centriole that is devoid of hPOC5 during the cell cycle 
preceding the S­phase arrest. Thus, hPOC5 may be required to 
regulate centriole elongation before its incorporation within 
procentrioles (Fig. 8). This could imply the existence of an intra–
S phase mechanism regulating centriole duplication. Alterna­
tively, hPOC5 could be recruited within procentrioles during 
wide range of centrosomal components leads to a cell cycle ar­
rest at the G1/S transition (Srsen et al., 2006; Mikule et al., 
2007). This arrest occurs before the initiation of centrosome du­
plication and of DNA replication and is p38, p53, and p21 de­
pendent (Srsen et al., 2006; Mikule et al., 2007). In addition to 
centrosome disruption, exogenous stress can also arrest RPE1 
cells in G1, suggesting that this arrest results from a broader 
range stress response (Uetake et al., 2007). The similarities be­
tween our results and the aforementioned studies suggest that 
hPOC5 depletion induces the same stress response in RPE1 
cells. In contrast, p53­defective cell lines like HeLa cells do not 
arrest in G1 after centrosome disruption (Srsen et al., 2006). We 
confirmed that p53 was fully inactive in the HeLa cells used in 
this study, as revealed by the lack of p21 up­regulation after ir­
radiation. We found that hPOC5­depleted HeLa cells were able 
to enter S phase, as supported by the fact that both initiation of 
centrosome duplication and DNA replication were taking place 
in these cells, but eventually failed to enter mitosis and under­
went cell death. Our results point to a specific requirement for 
hPOC5 during progression through S phase. However, whether 
the  observed  defect  in  cell  cycle  progression  results  from 
hPOC5 centriolar functions or from separate functions is not 
known at present.
hPOC5 is required for centriole elongation
Our results show that most of hPOC5­depleted cells arrest with 
duplicated centrosomes, each containing one full­length paren­
tal centriole and one short procentriole. EM of serial­sectioned 
cells revealed that the procentrioles are 40% as long as full­
length centrioles. In addition, the procentrioles retain features 
normally observed during early initiation of centriole duplica­
tion: they are formed of doublet microtubules instead of triplets, 
and they contain a very well­defined cartwheel structure, which 
are all features that are typical in procentrioles found during early 
S phase in mammalian cells (Robbins et al., 1968). We confirmed 
Figure 8.  Model for the role of hPOC5 in centriole assembly. In control cells, the duplication starts during late G1 or early S phase by the assembly of a 
precursor structure containing a cartwheel that contains centrin proteins (shaded in pink) but not hPOC5. Centrin proteins are likely to interact at this step 
with another unidentified centrin-binding protein. During early S phase, microtubule singlets then doublets are assembled around the cartwheel. During 
mid or late S phase, either (1) hPOC5 is required to initiate procentriole elongation and this, in turn, allows cell cycle progression, or (2) hPOC5 triggers 
procentriole elongation and performs an additional function required for progression through S phase independently. During G2 phase, hPOC5 (shaded 
in green) starts to accumulate in the distal lumen of procentrioles, concomitantly to its phosphorylation, and keeps accumulating during the subsequent cell 
cycle together with centrin.JCB • VOLUME 185 • NUMBER 1 • 2009   112
5-GGGTTAGTCAACCACTTTTATG-3 for the second reaction. The 1,728-bp 
cDNA is identical to the N terminus of BC010695 (bp 111–194) and to 
NM_152408 (bp 51–1694) for the rest of the sequence.
hPOC5 homologues were identified by BLAST (Basic Local Align-
ment Search Tool) analysis using either full-length hPOC5 or the 21-aa sig-
nature sequence (aa 349–369). hPOC5 and homologues were analyzed 
for coiled-coil regions using MacStripe2.0b1 software (http://www.york 
.ac.uk/depts/biol/units/coils/mstr2.html). Sequence alignment was per-
formed using ClustalW (http://www.ch.embnet.org/) and drawn using 
Boxshade at http://www.ch.embnet.org. The phylogenetic tree was con-
structed with the neighbor-joining method using ClustalW and drawn using 
Phylodendron at http://www.es.embnet.org/.
GST pull-downs
For coexpression, hPOC5 fragments F1 (aa 1–170), F2 (aa 101–435), 
and F3 (aa 371–575) were fused with GST in pGEX4-T1. hCen2 and 
hCen3 were cloned in pET29 (EMD) and cotransfected with F1–3 GST fu-
sions in Rosetta (DE3) E. coli host strain (EMD). Bacteria were induced for 
4 h at 37°C. Protein extracts (in 50 mM Tris, pH 8, 150 mM NaCl, 1% 
NP-40, 0.5% deoxycholate, and 10 mM EGTA supplemented with prote-
ase inhibitors) were incubated with glutathione–Sepharose 4 Fast Flow (GE 
Healthcare), and beads were boiled in SDS sample buffer.
CBR1 (aa 117–197) and CBR2+3 (aa 222–304) as well as hCen2/3 
and human CaM 2 (available from GenBank/EMBL/DDBJ under acces-
sion no. NM_001743) were cloned in pGST-Parallel1 (Sheffield et al., 
1999). The GST fusions were produced as described for the F1–3 GST fu-
sions and bound to glutathione beads. hCen2/3 or CaM were digested by 
tobacco etch virus protease to remove GST and incubated at a concentra-
tion of 5 µM with GST-CBR beads. Beads and supernatants were boiled in 
SDS sample buffer, and equivalent amounts were loaded on a gel.
Antibodies
Full-length hPOC5 was cloned in pET15b vector (EMD) and expressed in 
E. coli. His-hPOC5 was purified under denaturing conditions using Ni-NTA 
resin (QIAGEN) and dialyzed before rabbit immunization (Agro-Bio). Anti-
bodies were purified over a GST-F1 column and a GST-F3 column and eluted 
at a low pH. Anti-hCen2 and anti-hCen3 antisera (Laoukili et al., 2000) were 
purified over a GST-hCen2 or a GST-hCen3 column, respectively. Anti-hCen1 
crude antiserum, which cross reacts with hCen2 (Laoukili et al., 2000), was 
used for Western blot analysis. CTR453 is a monoclonal antibody recognizing 
exon 29 of human AKAP450 (Keryer et al., 2003). GT335, a monoclonal anti-
polyglutamylated tubulin, was a gift from B. Eddé (Université de Paris 6, Paris, 
France; Wolff et al., 1992). Monoclonal anti–C-Nap1 was purchased from 
BD, monoclonal anti–proliferating cell nuclear antigen (PCNA) was purchased 
from Dako, and monoclonal anti–-tubulin (clone GTU88) was purchased 
from Sigma-Aldrich. The secondary antibodies used for immunofluorescence 
microscopy were Alexa Fluor 488–conjugated (Invitrogen) and Cy3/Cy5-
conjugated (Jackson ImmunoResearch Laboratories) donkey IgGs.
Cell fractionation and Western blotting
Nucleus/centrosome fractions from HeLa and KE37 cells were prepared as 
follows: cells were resuspended at 10
7 cells/ml in lysis buffer (10 mM Tris, 
pH 7.5, 10 mM NaCl, 3 mM MgCl2, 1% NP-40, and 10% sucrose with pro-
tease inhibitors) and centrifuged at 100 g. The pellet containing the nuclei 
was incubated at RT in the same volume of digestion buffer (10 mM K-Pipes, 
pH 6.8, 50 mM NaCl, 3 mM MgCl2, 1 mM EGTA, 10% sucrose, 0.1 mg/ml 
DNase I, and 0.1 mg/ml RNase A with protease inhibitors) for 30 min. After 
addition of (NH4)2SO4 and NaCl at final concentrations of 0.25 M and   
1 M, respectively, the extracts were centrifuged at 15,000 g over a cushion 
of 60% sucrose in digestion buffer. The nucleus/centrosome fractions were 
collected at the 10–60% sucrose interface. Isolated centrosome fractions 
from KE37 were prepared as previously described (Bornens and Moudjou, 
1999) and provided by C. Celati (Institute Curie, Paris, France).
For immunoprecipitation assays, affinity-purified anti-hPOC5, -hCen2, 
and -hCen3 antibodies or monoclonal anti-myc antibody 9E10 was bound 
to sheep anti–rabbit or anti–mouse IgG Dynabeads (M-280; Invitrogen), re-
spectively. Beads were incubated with HeLa cell extracts prepared in lysis 
buffer (50 mM Tris, pH 8, 150 mM NaCl, 1% NP-40, 0.5% deoxycholate, 
and 0.1% SDS supplemented with protease inhibitors) and analyzed by 
SDS-PAGE.
Protein dephosphorylation was performed as follows: nucleus/
centrosome fractions from HeLa cells or immunoprecipitated hPOC5 bound 
to Dynabeads (see previous paragraph) were incubated with 1,000 U   
-phosphatase (New England Biolabs, Inc.) in -phosphatase buffer supple-
mented with 2 mM MnCl2, 0.15 M NaCl, and protease inhibitors.
S phase in amounts lower than the detection limit in our experi­
mental conditions.
In conclusion, our data show that hPOC5 is a centrin­
binding protein essential for centriole elongation and cell cycle 
progression. Whether the S­phase delay observed in hPOC5­ 
depleted cells results from inhibition of centriole elongation or 
from another hPOC5­dependent function is an important ques­
tion that will deserve further work. Our data also support the idea 
that daughter centrioles are assembled in two main steps coupled 
to cell cycle progression. The first step corresponds to the assem­
bly of a procentriole organized around a cartwheel structure. The 
second step, for which hPOC5 is required, corresponds to the   
assembly of the distal portion of the centriole. This assembly 
scheme may be related to what occurs in the green algae C. rein-
hardtii. In this species, the two probasal bodies remain of the 
length of the cartwheel structure for most of interphase, elongat­
ing only during G2 phase (Dutcher, 2003; Piasecki et al., 2008). 
Although occurring in a different timing in human cells, the 
mechanisms that control the initiation of elongation may be evo­
lutionarily conserved. Interestingly, the genomes of Drosophila 
and C. elegans, which are two species that assemble modified 
short centrioles (Callaini et al., 1997; Pelletier et al., 2006), do not 
contain POC5 homologues.
Materials and methods
Cell culture
HeLa and RPE1 cells (Clontech Laboratories, Inc.) were cultured in DME or 
DME/F-12 (Invitrogen), respectively, supplemented with 10% fetal calf serum 
(Biowest), 100 U/ml penicillin, and 100 µg/ml streptomycin (Invitrogen). 
HeLa cells expressing GFP-hCen1 have been described previously (Piel et al., 
2000). RPE1 cells expressing the same construct were obtained according to 
the same protocol. For DCen measurements, GFP-Cen1–expressing HeLa cells 
were either synchronized by a double thymidine block (18-h block, 10-h re-
lease, and 14-h block) using 2 mM thymidine or collected by mitotic shake-
off and were replated in the presence of 2 mM HU for 37 h.
Cell irradiation
Cells grown to semiconfluency were irradiated (10 Gy) in PBS at RT using 
a 
137Cs source. After 7 h at 37°C in normal medium, cells were scrapped 
in PBS and sedimented at low speed, and the pellet was solubilized in boil-
ing sample buffer for SDS-PAGE analysis.
Yeast two-hybrid analysis
A cDNA encoding full-length hCen2 was cloned into the pB29 bait plasmid 
derived from pFBL23 (Beranger et al., 1997). A C-terminal domain of hCen2 
(aa 93–173) was inserted into the pB27 bait plasmid derived from the origi-
nal pBTM116 (Vojtek and Hollenberg, 1995). Random-primed cDNA librar-
ies from human placenta and the PAZ-6 cell line (preadipocyte) poly(A)
+ 
RNA  were  constructed  into  the  pP6  plasmid  derived  from  the  original 
pGADGH (Bartel et al., 1993). The libraries were transformed into the Y187 
yeast strain, and 10
7 independent yeast colonies were collected, pooled, 
and stored at 80°C as equivalent aliquot fractions of the same library. The 
screens were performed to ensure a minimum of 5 × 10
7 interactions tested 
using a mating protocol previously described (Fromont-Racine et al., 1997). 
Prey fragments of the positive clones were amplified by PCR and sequenced 
at their 5 and 3 junctions on a sequencer (PE3700; Applied Biosystems). 
The resulting sequences were used to identify the corresponding gene in the 
GenBank database (National Center for Biotechnology Information) using a 
fully automated procedure.
hPOC5 cloning and bioinformatics analyses
Reverse transcription was performed on HeLa cell total RNA extracts   
using the hPOC5-specific primer, 5-AACCAAAAGACTTCTAACCCTT-3. 
hPOC5 single-strand cDNA was amplified by two successive PCR reactions 
using reverse transcription primer and 5-TGACACTGCAGCTGCGAC-3 
for  the  first  reaction  and  5-GGAATTCATGTCATCAGATGAG-3  and   113 hPOC5 IS REQUIRED FOR CENTRIOLE ELONGATION • Azimzadeh et al.
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